Next-Generation Sequencing Market to Exceed USD 23.59 Billion by 2027, Fueled by Advancements in Technology

The Next-Generation Sequencing (NGS) Market is expected to grow exponentially in the coming years. NGS refers to a high-throughput DNA sequencing technology that allows for the analysis of millions of DNA sequences simultaneously. The market is primarily driven by the increasing demand for personalized medicine and the rising prevalence of cancer and genetic disorders. The global Next Generation Sequencing Market is expected to reach USD 23.59 Billion by 2027, according to a new report by Emergen Research. The benefits of high-performance sequencing compared to other generations, such as the sanger-seq and microarrays, are one of the main drivers of the Next Generation Sequencing (NGS) industry.

One of the major drivers of the NGS market is the increasing demand for personalized medicine. NGS technology is being widely used in the field of personalized medicine for the diagnosis and treatment of various diseases. The ability of NGS to sequence the entire genome of an individual in a short period of time makes it possible to identify genetic variations that are responsible for certain diseases. This, in turn, allows for the development of personalized treatment plans based on an individual's genetic makeup.

Another driver of the NGS market is the rising prevalence of cancer and genetic disorders. According to the World Health Organization (WHO), cancer is the second leading cause of death globally, accounting for an estimated 9.6 million deaths in 2018. NGS technology is being increasingly used in cancer research to identify genetic mutations that can be targeted for treatment. Similarly, NGS is also being used to diagnose and treat various genetic disorders such as cystic fibrosis, muscular dystrophy, and Huntington's disease.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/8

However, there are some factors that are restraining the growth of the NGS market. One of the major challenges faced by the market is the high cost of NGS instruments and reagents. The cost of NGS instruments and reagents is still prohibitively high for many research institutions and healthcare providers, especially in developing countries. Moreover, the lack of skilled professionals who can operate and interpret NGS data is also a major challenge for the market.

Despite these challenges, there are several growth factors that are expected to drive the NGS market in the coming years. One of the key growth factors is the increasing adoption of NGS technology in clinical applications. NGS technology is being increasingly used in clinical settings for the diagnosis and treatment of various diseases. The increasing adoption of NGS technology in clinical applications is expected to drive the growth of the market in the coming years.

Another growth factor for the NGS market is the increasing demand for NGS data analysis tools. With the increasing amount of NGS data being generated, there is a growing need for software tools that can analyze and interpret the data. The development of advanced NGS data analysis tools is expected to drive the growth of the market in the coming years. According to the National Human Genome Research Institute (NHGRI), the cost of sequencing a human genome has decreased significantly in the past decade. In 2019, the cost of sequencing a human genome was approximately USD 1,000, compared to over USD 1 million in 2001. This significant decrease in the cost of sequencing a human genome is expected to drive the growth of the NGS market in the coming years.

In conclusion, the NGS market is expected to grow significantly in the coming years, driven by the increasing demand for personalized medicine and the rising prevalence of cancer and genetic disorders. However, the market still faces challenges such as the high cost of NGS instruments and reagents and the lack of skilled professionals. Nevertheless, the increasing adoption of NGS technology in clinical applications, the demand for NGS data analysis tools, and the decreasing cost of sequencing a human genome are expected to drive the growth of the market in the coming years.

Major Companies and Competitive Landscape:

Key participants include Deere & Company, Topcon Positioning Systems, Trimble, Inc., DeLaval, Antelliq, Heliospectra, Afimilk Ltd., InnovaSea Systems, AKVA group, and Nexus Corporation, among others.

The competitive landscape for the Next-Generation Sequencing (NGS) market is highly fragmented, with several players operating in the market. The market is dominated by a few major players, including Illumina, Inc., Thermo Fisher Scientific Inc., and Pacific Biosciences of California, Inc. These companies are investing heavily in research and development activities to develop innovative products and stay ahead of the competition.

Illumina, Inc. is one of the leading players in the NGS market. The company offers a range of NGS products and services, including sequencing platforms, library preparation kits, and data analysis tools. Illumina's NGS platforms are widely used in research institutions and clinical settings for a variety of applications such as cancer research, genetic disease diagnosis, and drug discovery.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/8

Thermo Fisher Scientific Inc. is another major player in the NGS market. The company offers a wide range of NGS products and services, including sequencing platforms, library preparation kits, and data analysis tools. Thermo Fisher Scientific's NGS platforms are widely used in clinical settings for a variety of applications such as genetic disease diagnosis and cancer research.

Pacific Biosciences of California, Inc. is a relatively new player in the NGS market, but the company has made significant strides in recent years. Pacific Biosciences' NGS platform, the PacBio Sequel II System, offers long-read sequencing capabilities, which makes it ideal for applications such as de novo genome sequencing and transcriptome analysis.

The NGS market is highly competitive, and companies are constantly striving to differentiate themselves by developing innovative products and providing superior customer service. In addition to the major players mentioned above, there are also several smaller companies and startups operating in the market, each with their own unique offerings.

Segmentation Insights for Next-Generation Sequencing Market

The technology segment includes whole genome sequencing, whole exome sequencing, targeted sequencing and resequencing. Whole genome sequencing is expected to dominate the market due to its increasing use in research and clinical settings for a variety of applications, including cancer research and genetic disease diagnosis.

The Workflow Segment includes pre-sequencing, sequencing, and NGS data analysis. The sequencing segment is expected to dominate the market due to the high demand for sequencing platforms and services.

The Application Segment includes clinical investigation, oncology, reproductive health, HLA typing/immune system monitoring, metagenomics, epidemiology and drug development, agrigenomics and forensics, and consumer genomics. The oncology segment is expected to dominate the market due to the increasing prevalence of cancer and the growing demand for personalized medicine.

The End-Use Segment includes academic research, clinical research, hospitals and clinics, pharma and biotech entities, and others. The academic research segment is expected to dominate the market due to the high demand for NGS technologies in academic research institutions.

Lastly, the report provides a regional outlook for the global cloud computing market, which includes North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The report highlights several countries within each region, such as the U.S., Canada, Germany, the U.K., China, India, Brazil, and Saudi Arabia, among others.

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/next-generation-sequencing-market

Eric Lee
Corporate Sales Specialist
14671 110 Avenue, Surrey, British Columbia, V3R2A9
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions.

This release was published on openPR.